Executive perspectives: Robert HuginAs pharmaphorum continues to connect with those senior executives who are shaping the future of the pharmaceutical industry, Share XExecutive perspectives: Robert Huginhttps://pharmaphorum.com/views-and-analysis/executive-perspectives-robert-hugin/
A history of Abbott and AbbVieThis month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – Share XA history of Abbott and AbbViehttps://pharmaphorum.com/views-and-analysis/a-history-of-abbott-and-abbvie/
Pharma news highlights: Chinese bribery scandal, possible pharma mergerEd Silverman shares his thoughts on some of the latest pharma news stories from the last four weeks, Share XPharma news highlights: Chinese bribery scandal, possible pharma mergerhttps://pharmaphorum.com/views-and-analysis/pharma-news-highlights-chinese-bribery-scandal-possible-pharma-merger-2/
Building momentum to end AIDS, TB and malariaIn Eli Lilly and Company’s latest article, Evan Lee discusses how the pharma industry is building momentum in Share XBuilding momentum to end AIDS, TB and malariahttps://pharmaphorum.com/views-and-analysis/building-momentum-to-end-aids-tb-and-malaria/
Why is rare disease funding rare?Oliver Timmis explores the problems associated with securing funding for rare disease research and questions why more funding Share XWhy is rare disease funding rare?https://pharmaphorum.com/views-and-analysis/why-is-rare-disease-funding-rare/
The Global Publication Survey (GPS): update and implicationsTom Grant and Professor Karen Woolley provide us with an update to ISMPP’s Global Publication Survey for medical Share XThe Global Publication Survey (GPS): update and implicationshttps://pharmaphorum.com/views-and-analysis/the-global-publication-survey-gps-update-and-implications/
Pharmacovigilance and risk management information in centralised applications in the EUVéronique Basch provides us with an overview of the new European Union pharmacovigilance legislation and how it affects Share XPharmacovigilance and risk management information in centralised applications in the EUhttps://pharmaphorum.com/views-and-analysis/pharmacovigilance-and-risk-management-information-in-centralised-applications-in-the-eu/
Breakthrough skin cancer surgery: Interview with Dr PiaseckiSkin cancer is the third most common form of cancer – yet it’s still the one that has Share XBreakthrough skin cancer surgery: Interview with Dr Piaseckihttps://pharmaphorum.com/views-and-analysis/breakthrough-skin-cancer-surgery-interview-with-dr-piasecki/
Why digital needs to be brand specificIn this article, Cognite’s Mike Young discusses the importance of having a brand-specific communication strategy in order to Share XWhy digital needs to be brand specifichttps://pharmaphorum.com/views-and-analysis/why-digital-needs-to-be-brand-specific/
